Congenica
Congenica is a leading provider of clinical decision support software and services which has developed the gold-standard platform, Sapientia, for analysis, interpretation and generation of clinically actionable reports on patient derived genomic data. Headquartered at the Wellcome Genome Campus, Cambridge, UK, Sapientia’s underlying technology was spun out of the pioneering research from the Sanger Institute and the platform continues to be developed by the well-renowned scientific staff and advisers.
Congenica aims to integrate genomics into healthcare by providing clinical genome analytics to support medical practitioners treating patients with genetic diseases, and thereby improving human health and personalised patient care. The company is at the forefront of partnering with leading clinical research and healthcare providers, charities and patient advocacy groups and diagnostic companies to create new medical paradigms in orphan diseases.
In the media
30th April 2019
What drives the stand out success of genomics biotech pioneer, Congenica?
15th April 2019
Next Generation Sequencing (NGS) Data Analysis Market – Outlook on Emerging Developments 2025
Some of the leading companies in the global NGS data analysis market includes Illumina Inc., Ingenuity, Station X Inc., DNAnexus SevenBridges Genomics, Genalice, Congenica, Omicia Inc., WuXiNextCODE, Bluebee, and Edico Genome. About
15th April 2019
Next Generation Sequencing (NGS) Data Analysis Market – Outlook on Emerging Developments 2025
Some of the leading companies in the global NGS data analysis market includes Illumina Inc., Ingenuity, Station X Inc., DNAnexus SevenBridges Genomics, Genalice, Congenica, Omicia Inc., WuXiNextCODE, Bluebee, and Edico Genome. About